Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 31;13(3):383-396.
doi: 10.21037/tau-23-518. Epub 2024 Mar 18.

Papillary renal neoplasm with reverse polarity: an observational study of histology, immunophenotypes, and molecular variation

Affiliations

Papillary renal neoplasm with reverse polarity: an observational study of histology, immunophenotypes, and molecular variation

Huan Han et al. Transl Androl Urol. .

Abstract

Background: Papillary renal neoplasm with reverse polarity (PRNRP) is a novel entity with unique clinicopathological characteristics, and only a small number of patients with PRNRP have been described.

Methods: We retrospectively analyzed the data for nine patients with PRNRP and evaluated differences in the clinical, histomorphological, immunohistochemical, and molecular features; prognosis; and differential diagnosis of PRNRP from other renal tumors with papillary structure.

Results: There were six males and three females aged 36 to 74 years (mean: 62.33 years; median: 68 years). All the tumors were solitary and ranged from 1 to 3.7 cm (mean: 2.17 cm; median: 2 cm), with three and six tumors arose in the left and right renal tract, respectively. Pathologically, PRNRP is a small, well-circumscribed neoplasm with predominant papillary formations. The lining epithelium is composed of a monolayer of cuboidal to low-columnar cells with low-grade nuclei arranged against the apical pole of the tumor cells. Edema, mucinous degeneration, and hyaline degeneration are found in the fibrovascular cores. Foamy macrophages, psammoma bodies, hemosiderin deposition, and infiltrative tumor boundaries were present in some patients. Immunohistochemically, all tumors showed diffuse positive staining for GATA3. Sanger sequencing confirmed the presence of KRAS mutation in seven patients. All patients had a good prognosis after surgery and were relapse free. Positive staining for GATA3 and negative staining for vimentin were the most significant markers for differentiating PRNRP from other renal tumors with analogous structure.

Conclusions: These findings suggested that PRNRP is a distinctive subtype of renal tumor with specific pathological features and indolent behaviors that should be distinguished from other renal tumors, especially papillary renal cell carcinoma. A monolayer of tumor cells with an inverted nuclear pattern, positive staining for GATA3, and KRAS mutation are essential for pathological diagnosis. Owing to its satisfactory prognosis, the surveillance and follow-up of patients with PRNRP should be additionally formulated.

Keywords: GATA3; KRAS mutation; Papillary renal cell carcinoma (PRCC); renal tumor.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tau.amegroups.com/article/view/10.21037/tau-23-518/coif). The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Gross appearance of papillary renal neoplasm with reverse polarity. The cut surface of the tumor was grayish yellow in color, solid to medium in quality, and had a clear boundary with the surrounding renal tissue.
Figure 2
Figure 2
Microscopy images of papillary renal neoplasm with reverse polarity (hematoxylin-eosin staining). (A) Predominantly thin filiform papillae of the tumor (×100); (B) tubular architecture of the tumor (×200); (C) fused papillae structure of the tumor (×100); (D) monolayer of tumor cells with inverted nuclei (×400); (E) foamy macrophages in the tumor (×200); (F) sporadic psammoma in the tumor (×200); (G) hemorrhage in the tumor (×100); (H) a small amount of lymphocyte infiltration in the papillary axis (×200); (I) no pseudocapsule at the tumor boundary (×100).
Figure 3
Figure 3
Immunohistochemical images of papillary renal neoplasm with reverse polarity. (A) GATA3-positive cells (×200); (B) vimentin-negative cells (×200); (C) CK7-positive cells (×200); (D) MUC1-positive cells (×200); (E) P504S-positive cells (×200); (F) low percentage of Ki-67-positive cells (×200).
Figure 4
Figure 4
Molecular variation in papillary renal neoplasm with reverse polarity. (A) Representative results of p.G12D; (B) representative results of p.G12V. Arrow: mutation site.

Similar articles

References

    1. Lobo J, Ohashi R, Amin MB, et al. WHO 2022 landscape of papillary and chromophobe renal cell carcinoma. Histopathology 2022;81:426-38. 10.1111/his.14700 - DOI - PubMed
    1. Akhtar M, Al-Bozom IA, Al Hussain T. Papillary Renal Cell Carcinoma (PRCC): An Update. Adv Anat Pathol 2019;26:124-32. 10.1097/PAP.0000000000000220 - DOI - PubMed
    1. Delahunt B, Eble JN. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol 1997;10:537-44. - PubMed
    1. Moch H, Humphrey PA, Ulbright TM, et al. WHO classification of tumours of the urinary system and male genital organs. 4th edition. Lyon: IARC Press; 2016. - PubMed
    1. WHO classification of tumours editorial board. WHO classification of tumours of the urinary and male genital organs. 5th edition. Lyon: IARC Press; 2022.